As of 4:00pm ET
| +0.045 / +2.24%|
The 1 analysts offering 12-month price forecasts for Repros Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +143.90% increase from the last price of 2.05.
The current consensus among 2 polled investment analysts is to Buy stock in Repros Therapeutics Inc. This rating has held steady since August, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.